PharmAsia News
Fortune
The Scientist
PharmaWeek
DDNews

China’s Biotech Pioneers

November 2010 – Fortune

China’s biotech pioneers; Mireille Gingras and Xian Ping Lu are two unlikely partners, but together they plan to unleash China’s young pharma industry.

webRead Full Article Online

Local Companies See Growth Opportunities in China

March 2010 – San Diego Business Journal
by Heather Chambers

BIOCOM to sign Memoradum of Understanding with Beijing Development Association

pdfRead Full Article

Year of the Compound

June 2009 – The Scientist
by Elie Dolgin

Will a novel codevelopment model open up China’s drug discovery platform?

pdfRead Full Article

The Future of Ancient Cures

May 2009 – Scientific American

Turning traditional Chinese medicine modern and leading the way for new drugs
by Mara Hvistendahl

Wolfberry, licorice and caterpillar fungus. Such substances don’t sound like the makings of modern medicine, but they might soon be just that. China’s current five-year plan lists the “modernization” of traditional Chinese medicine (TCM) as one of 12 focal points, allotting 1 billion yuan ($146 million) for the task. The goal is to move away from philosophies like yin-yang and meridian theory and toward science-by introducing randomized, double-blind, placebo controlled trials…

pdfRead Full Article

HUYA Looks to Ride the Wave of Chinese Innovation

February 6, 2009 – SCRIP World Pharmaceutical News

The pursuit of cost-effective innovation may have led many multinationals to build up their R&D activities in China recently, but one entrepreneur spotted the vast potential of the country’s research expertise several years ago. HUYA Bioscience International’s founder, president and CEO Dr Mireille Gingras, talks to Scrip’s Asia editor Ian Haydock…

pdfRead Full Article

HUYA Bioscience Taps into China for Novel Drug Candidates

January 8, 2009 – Xconomy.com

HUYA sources novel drug candidates to meet the growing needs of big pharma drug pipelines, interview with Mireille Gingras, CEO HUYA Bioscience

If there was an “ah-ha” moment for Huya Bioscience International, it occurred in 2004, when founder Mireille Gingras was working as a consultant for mid-size biotech companies…

pdfRead Full Article

HUYA: A Conduit Between Chinese Pharma and US Clinical Trials

November 13, 2008 – PharmaWeek

HUYA’s innovative Integrated Co-development Model for drug development is validated with Chinese-based Phase I clinical trial results on Chidamide (HBI-8000), a novel histone deacetylase (HDAC) inhibitor of the benzamide class.

pdfRead Full Article

Drug Discovery in China

October 2008 – Nature Reviews

Organizations worldwide have shown growing interest in China as a location for drug discovery and development. This month, we feature two people closely involved in harnessing the therapeutic potential of compounds discovered in China.

pdfRead Full Article

GEN Reviews BIO 2008

August 1, 2008 – Genetic Engineering News

GEN Reviews BIO 2008: Tips for Doing Business in China and India Risks, IP, Opportunities, and Approaches Are Morphing at Breakneck Speed

pdfRead Full Article

Huya Targeting China to Accelerate Drug Production

July 21, 2008 – San Diego Business Journal

Risk reduction has always been an attractive business practice, but it has an especially sweet-sounding ring for drug firms looking to bring new medicines onto the market.

pdfRead Full Article